cilostazol

Generic: cilostazol

Labeler: slate run pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler slate run pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 50 mg/1

Manufacturer
Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-156
Product ID 70436-156_45be0b2e-7ae1-42d2-e063-6394a90a1da6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077208
Listing Expiration 2026-12-31
Marketing Start 2018-01-01

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436156
Hyphenated Format 70436-156

Supplemental Identifiers

RxCUI
242461 242462
UPC
0370436156061 0370436157068
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077208 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (70436-156-06)
source: ndc

Packages (1)

70436-156-06 60 TABLET in 1 BOTTLE (70436-156-06)

Ingredients (1)

cilostazol (50 mg/1)

Linked Drug Pages (1)

Cilostazol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "45be0b2e-7ae1-42d2-e063-6394a90a1da6", "openfda": {"nui": ["N0000175598", "N0000175086"], "upc": ["0370436156061", "0370436157068"], "unii": ["N7Z035406B"], "rxcui": ["242461", "242462"], "spl_set_id": ["db0278e9-4ece-4aaf-9216-6bcbec58206a"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (70436-156-06)", "package_ndc": "70436-156-06", "marketing_start_date": "20210416"}], "brand_name": "Cilostazol", "product_id": "70436-156_45be0b2e-7ae1-42d2-e063-6394a90a1da6", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "70436-156", "generic_name": "cilostazol", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "50 mg/1"}], "application_number": "ANDA077208", "marketing_category": "ANDA", "marketing_start_date": "20180101", "listing_expiration_date": "20261231"}